The University of Calgary (UCalgary) intends to establish a contract with CRB Canada Inc. to provide Basis of Design (BOD) and Detailed Design (DD) for a cGMP compliant CART-T cell therapy manufacturing facility. The facility will be approximately 2000 square feet with an approximately 8000 square foot academic lab within the Arthur Child Comprehensive Cancer Centre. CRB Canada Inc. will build off the feasibility study and conceptual technical design with the regulatory and architectural strategies they completed January 2025.
The University of Calgary (UCalgary) intends to establish a contract with CRB Canada Inc. to provide Basis of Design (BOD) and Detailed Design (DD) for a cGMP compliant CART-T cell...
Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.